Sort
15,842 grants matching “pancreatic cancer”
Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer
$442,114Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2025 · CA
Regulatory Pathways Compromised by PRMT5 Inhibition in Cancers with MTAP Loss
$442,089Frederick H Wilson · Yale University · R37 · FY2025 · CA
Palliative Care: Maximizing Patient Preference
$441,993Donald H Taylor · Duke University · R01 · FY2012 · HS
Discovery and Development of Cancer Glycomarkers
$441,980James Michael Pierce · University Of Georgia · U01 · FY2014 · CA
Chemical pancreatectomy for chronic pancreatitis and pancreatic cancer
$441,949George K. Gittes · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2015 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · University Of California-Irvine · R01 · FY2018 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2014 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2016 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2017 · CA
Defining epigenetic signaling to reshape pancreatic tumor microenvironment
$441,899Jiaqi Shi · University Of Michigan At Ann Arbor · R37 · FY2024 · CA
Branched chain amino acids and pancreatic cancer
$441,899Kathryn Elaine Wellen · University Of Pennsylvania · R01 · FY2024 · CA
Enhancing Tumor Antigen Presentation with Complement Targeted Nanoparticles
$441,796Max Peter Kullberg · University Of Alaska Anchorage · R15 · FY2022 · CA
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$441,779Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Pancreatic Cancer Cell Mechanics and Imaging
$441,510Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2014 · CA
Tumor-priming Microparticles for Pancreatic Cancer
$441,343Ze Lu · Optimum Therapeutics, Llc · R44 · FY2006 · CA
Targeting Epigenomic Regulators at the Replication Fork in PDAC
$441,252Gwen Lomberk · Medical College Of Wisconsin · R01 · FY2022 · CA
4'-Substituted nucleoside analogs as anticancer drugs
$441,240John A Secrist · Southern Research Institute · R01 · FY2012 · CA
4'-Substituted nucleoside analogs as anticancer drugs
$441,240John A Secrist · Southern Research Institute · R01 · FY2011 · CA
The Antigen Targeting Core
$441,143Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer
$441,011Michael Bouvet · University Of California, San Diego · R01 · FY2023 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA
$440,978Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2015 · CA
Rapid Quantitation of Small RNA
$440,975Gary J Latham · Ambion Diagnostics, Inc. · R44 · FY2007 · GM
Project 2 NF-#B regulation in muscle wasting and pancreatic cancer-induced cachexia
$440,884Denis C Guttridge · Medical University Of South Carolina · P01 · FY2025 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$440,875Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA